Navigation Links
Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program

ATLANTA--(BUSINESS WIRE)--May 14, 2007--Sciele Pharma, Inc. (NASDAQ:SCRX) today announced the successful completion of the clinical trial program for its new Sular formulation. The study results showed that the new Sular formulation is bioequivalent to Sciele's currently marketed Sular. The new Sular formulation utilizes SkyePharma's (LSE:SKP) patented Geomatrix technology, which is designed to provide a lower dose of Sular for each of its current doses.

The data from this study will be combined with the results from the previous clinical trial in the Company's new Sular formulation supplemental New Drug Application (sNDA) filing. As previously announced, the Company confirms its expectation to file an sNDA with the U.S. Food and Drug Administration by end of the second quarter of 2007.

About Sciele Pharma, Inc.

Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes and Women's Health. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes, and its Women's Health products are designed to improve the health and well-being of women and mothers and their babies. Founded in 1992 and headquartered in Atlanta, Georgia, Sciele Pharma employs more than 800 people. The Company's success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform - an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity, and Teamwork.

About SkyePharma PLC

Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and life-cycle extension. The Company has ten approved products in the areas of oral, inhalation and topical delivery. The Company
'"/>




Page: 1 2 3 4

Related medicine technology :

1. SkyePharma and Sciele Pharma Announce Successful Completion of New Sular Formulation Clinical Trial Programme
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:5/22/2013)... , May 22, 2013 ... is investigating claims on behalf of investors of Intuitive ... ISRG ) (CUSIP: 46120E602) who purchased Intuitive Surgical ... 2013 (the "Class Period"). Such investors are advised to ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
(Date:5/22/2013)... , May 22, 2013   ... successful completion of its global Phase III ... internally developed program for the management of ... formulation technology.  USL255 is specifically engineered to ... in topiramate blood levels observed with currently ...
(Date:5/22/2013)... , May 22, 2013  Generex Biotechnology Corporation ... demonstrating the superiority of the AE37 breast cancer vaccine ... ( www.antigenexpress.com ). The presentations will be made at ... Oncology (ASCO) to be held in Chicago ... The presentation entitled " Booster inoculations of ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4
... At MEDRAD, Inc., community outreach is a ... annual Day of Caring, a company-sponsored event where ... workday volunteering in their communities. ... Over 1000 MEDRAD employees will participate in the ...
... Sept. 17 ThanksUSA, a charitable effort to ... need-based scholarships, recently distributed 150 scholarship letters worth ... active-duty military. Through a $25,000 contribution from the ... eight scholarships went specifically to students majoring in ...
Cached Medicine Technology:MEDRAD Employees Demonstrate Longstanding Commitment to Community 2MEDRAD Employees Demonstrate Longstanding Commitment to Community 3ThanksUSA Awards Scholarships to Military Families With the Help of the National Association of Chain Drug Stores 2
(Date:5/22/2013)... Pamela Isom, President and CEO of ... Journal’s 2013 Women of Influence Award in recognition for ... The reception took place on Thursday, May 2 at ... is particularly humbling for the 5,000 people ICE Safety ... is to recognize the four to nine lives saved ...
(Date:5/22/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) ... children who die each year awaiting an organ donation ... increasing numbers of children are receiving donor organs. ... donors expanded to include not just patients who,ve experienced ... of death." But it,s unclear how much that ...
(Date:5/22/2013)... of Illinois researcher says that the cornerstone of our ... more people to participate in the Supplemental Nutrition Assistance ... Gundersen, SNAP, formerly known as the Food Stamp Program, ... some additional improvements could be even more successful at ... U of I professor of agricultural and consumer economics ...
(Date:5/22/2013)... supplement of up to 1,000 mg per day can ... lead author was Lisa Langsetmo, a Ph.D. Research Associate ... David Goltzman, Division of Endocrinology and Metabolism in the ... researcher in the Musculoskeletal Disorders axis at the Research ... are published in the Journal of Clinical Endocrinology ...
(Date:5/22/2013)... the parents are married are less likely to be ... the University of Houston. , "Childhood obesity is a ... one-third of all U.S. children ages 2-17 overweight or ... sociology at Rice and director of Rice,s Kinder Institute ... been conducted to explore the impact of family structure ...
Breaking Medicine News(10 mins):Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 2Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 3Health News:Calcium supplements linked to longer lifespans in women 2Health News:Children of married parents less likely to be obese 2Health News:Children of married parents less likely to be obese 3
... India's Knowledge Commission will soon come up with recommendations ... level to make it more competitive//, and to accommodate ... ,"We will come up with recommendations on the undergraduate ... he said, adding that a group has also been ...
... Research Institute at the University of Massachusetts listed about ... pollution//. This list is officially called the Toxic 100. ... of air pollution. This is based on air releases ... United States. , The various factors that ...
... to cancer is expected to be unsuccessful. Statisticians with the ... invested in the hunt for common inherited genetic variants that ... that there are a number of problems when doing such ... is that common genes are unlikely to exist nor ...
... enter the Guinness Book of World Records, but her achievement ... of 11 definitely makes her a wonder-kid. ,Born ... a medical practitioner, passed her Class 12 exam in the ... in the Basbadanpura area of this Rajasthan capital. ...
... coffee, coffee drinkers finally have something to cheer about. A ... three cups of coffee are protected from heart disease to ... Women's Health Study and has found that up to 60 ... free radicals in our bodies may come from coffee. ...
... be presented at the 29th Annual Scientific Sessions of ... that following// a methodical desensitization protocol might help patients ... to prevent the formation of new blockages in coronary ... to patients and physicians, and can lead to discontinuation ...
Cached Medicine News:Health News:Jaipur Girl’s Rare Feat: The Youngest To Pass Class 12 At The Age Of 1 2Health News:Clopidogrel Allergy Can Be Tackled By Methodical Desensitization 2
ISI Alumi-Hand is the safe, sterile, ready-to-use ,surgical hand immobilizer....
TeleRehab Advantage is a monitoring system that automates the generation of outcomes data. Patient information and session information is automatically transferred from the monitoring program to Outc...
ISI Ultra-Light Specialty Table offers the ultimate accessibility for surgeons, technicians and equipment during upper extremity surgeries....
MagPrep® Streptavidin Beads are encapsulated super-paramagnetic polystyrol particles coated with streptavidin. The beads have a diameter of 1 m and are provided as a stabilized aqueous suspensio...
Medicine Products: